Imalek Tablet (Imatinib Mesylate): Anti-Cancer Tablet | For Chronic Myeloid Leukemia (CML) & Gastrointestinal Stromal Tumors (GIST) Management
Imalek Tablet is a targeted medicine containing imatinib, commonly formulated as imatinib mesylate. It belongs to the tyrosine kinase inhibitor group and is used to treat certain types of blood cancers, including chronic myeloid leukemia (CML), and specific gastrointestinal stromal tumours (GIST). It works by blocking proteins involved in abnormal cell growth.
Product Overview
Imalek Tablet is a targeted medicine that contains imatinib, commonly formulated as imatinib mesylate. It belongs to a group of medicines called tyrosine kinase inhibitors, which work by blocking specific proteins involved in abnormal cell growth. Imatinib is used to manage certain blood cancers and specific tumours, depending on the diagnosis and relevant test results.
The medicine works by interrupting signals that help affected cells grow and multiply. Its use is determined by the type of condition, the proteins involved, and the individual’s response to treatment.
How Imalek Tablet Works
Imatinib blocks the activity of certain tyrosine kinase proteins. These proteins normally help regulate cell signalling, but in some conditions, they become overactive and contribute to abnormal cell growth.
In chronic myeloid leukemia (CML), for example, imatinib targets the abnormal BCR-ABL protein. In certain gastrointestinal stromal tumours (GIST), it may act on KIT or PDGFRA proteins when the tumour has changes that respond to the medicine. By blocking these signals, Imalek Tablet can help control the growth of affected cells.
Importance of Consistent Treatment
Imatinib treatment may continue for an extended period, depending on the condition and the response achieved. Taking the medicine consistently helps maintain the intended treatment effect. Missing doses or stopping treatment without guidance may affect disease control.
If you miss a dose, follow the instructions in the product leaflet or contact the treating specialist for advice. Do not take an extra dose to compensate unless specifically instructed.
Taking Imalek Tablet as Directed
Imalek Tablet is generally taken with food and a full glass of water to help reduce irritation in the stomach and food pipe. It should be taken at the recommended times each day. The dose and duration vary according to the condition, treatment response, and individual health factors.
If swallowing the tablet is difficult, ask a pharmacist or treating specialist about the correct method for the specific product. Do not crush, split, or otherwise alter the tablet unless you have been advised that doing so is appropriate.
Storage and Handling
Store Imalek Tablet according to the instructions on the packaging. The product information for Imalek 400 mg specifies storage below 30°C. Keep the tablets protected from excess moisture and out of reach of children, and check the expiry date before use.
Summary
Imalek Tablet contains imatinib mesylate, a targeted medicine belonging to the tyrosine kinase inhibitor group. It blocks specific proteins involved in abnormal cell growth and is used for selected blood cancers, gastrointestinal stromal tumours, and other approved conditions. The appropriate dose, duration, and monitoring schedule depend on the diagnosis and individual response. Consistent use and regular follow-up are important parts of treatment management.
Precaution
1. Follow the Recommended Dose
Take Imalek Tablet exactly as directed by the treating specialist. Do not change the dose or stop treatment without medical guidance.
2. Regular Blood Tests
Imatinib may affect blood cell counts. Attend recommended blood tests to monitor your response to treatment.
3. Liver Function Monitoring
Imalek Tablet may affect liver function. Report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.
4. Heart and Fluid Retention
Inform your treating specialist about existing heart problems or swelling. Seek prompt medical attention for sudden weight gain, significant swelling, or breathing difficulty.
5. Pregnancy and Breastfeeding
Discuss pregnancy plans or breastfeeding before starting treatment, as imatinib may pose risks.
6. Other Medicines
Share details of all medicines, vitamins, and herbal supplements you use, as some products may affect imatinib levels.
7. Driving and Daily Activities
If Imalek Tablet causes dizziness, blurred vision, or tiredness, avoid driving or operating machinery until you feel well.
Usage
Imalek Tablet contains imatinib, commonly formulated as imatinib mesylate. It is a targeted medicine used for certain blood cancers and gastrointestinal stromal tumours (GIST). Correct usage and regular monitoring help support consistent treatment.
How to Take Imalek Tablet
Take Imalek Tablet exactly as directed by the treating specialist. It is generally taken with a meal and a full glass of water to help reduce stomach irritation. Follow the recommended dose and schedule.
Recommended Dosage
The dose depends on the condition being treated, treatment response, and individual health factors. Do not change the dose or stop taking Imalek Tablet without medical guidance.
Important Instructions
Tell the treating specialist about all medicines, vitamins, and herbal supplements being used.
If swallowing the tablet is difficult, ask a pharmacist about the correct method for the specific product.
Keep follow-up appointments to monitor treatment response and overall health.
If vomiting occurs after a dose, seek guidance before taking another tablet.
Uses
Imalek Tablet contains imatinib, commonly formulated as imatinib mesylate. It is a targeted medicine that blocks specific proteins involved in abnormal cell growth. It is used to manage certain blood cancers and tumours when the condition responds to imatinib treatment.
1. Chronic Myeloid Leukemia (CML)
Imalek Tablet is used to treat certain forms of CML, a blood and bone marrow condition associated with the abnormal BCR-ABL protein.
2. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
It may be used as part of treatment for this type of leukemia, in which abnormal blood cells are associated with the BCR-ABL protein.
3. Gastrointestinal Stromal Tumours (GIST)
Imatinib is used for specific GISTs, which develop in the digestive tract and may involve changes in proteins such as KIT.
4. Other Specific Conditions
Depending on the approved indication and clinical assessment, imatinib may also be used for certain other blood disorders or uncommon tumours.
How Imalek Tablet Helps
Imatinib blocks selected tyrosine kinase proteins that send signals for abnormal cells to grow. Its benefits depend on the condition being treated and whether the affected cells respond to the medicine.
Side Effects
Imalek Tablet contains imatinib, a targeted medicine used for certain blood cancers and gastrointestinal stromal tumours (GIST). Like other medicines, it may cause side effects, which can vary depending on the dose and individual response.Nausea and vomiting: Some people may feel sick or experience vomiting.
Diarrhea: Loose stools or changes in bowel habits may occur.
Muscle cramps: Muscle tightness or cramping may develop during treatment.
Muscle and joint pain: Aches or discomfort may affect daily activities.
Swelling: Fluid retention can cause puffiness around the eyes or swelling in the legs.
Tiredness: Fatigue or low energy may occur.
Skin rash: Redness, itching, or other skin changes may develop.
Abdominal discomfort: Stomach pain or indigestion may occur.
How to Manage
Take Imalek Tablet according to the treating specialist’s instructions.
Attend recommended blood tests and follow-up appointments.
Report persistent vomiting, diarrhea, or swelling to the treating specialist.
Do not stop treatment or change the dose without medical guidance.
FAQs
1. What is Imalek Tablet used for?
Imalek Tablet is used to treat certain blood cancers, including CML and Ph+ ALL, and specific gastrointestinal stromal tumours (GIST).
2. What is the active ingredient in Imalek Tablet?
It contains imatinib, commonly formulated as imatinib mesylate.
3. How does Imalek Tablet work?
It blocks specific proteins that contribute to abnormal cell growth.
4. How should Imalek Tablet be taken?
It is generally taken with a meal and a full glass of water, as directed by the treating specialist.
5. Can Imalek Tablet be stopped suddenly?
Do not stop treatment without consulting the treating specialist.
6. Does Imalek Tablet require regular monitoring?
Yes, blood tests and other checks may be needed to monitor treatment response.
7. Can Imalek Tablet interact with other medicines?
Yes, some medicines, supplements, and herbal products may affect how imatinib works.
8. How should Imalek Tablet be stored?
Store it according to the product packaging instructions and keep it out of reach of children.
Interactions
Imalek Tablet contains imatinib, which may interact with certain medicines, supplements, and foods. These interactions can change the amount of medicine in the body and affect treatment. Inform your treating specialist about all products you use.
1. Antibiotics
Some antibiotics, such as clarithromycin, may affect how imatinib is processed. Seek professional advice before taking them together.
2. Antifungal Medicines
Medicines such as ketoconazole and itraconazole may increase imatinib levels and the chance of unwanted effects. Check with your treating specialist before combining them.
3. Seizure Medicines
Medicines such as carbamazepine and phenytoin may lower imatinib levels and reduce its effect. Your treatment plan may need review if these medicines are required.
4. Blood Thinners
Imatinib may affect the use of blood-thinning medicines such as warfarin. The treating specialist may recommend closer monitoring or another option.
5. Herbal Products and Supplements
St. John’s wort may reduce imatinib levels. Tell your healthcare professional about herbal products, vitamins, and supplements before using them.
6. Grapefruit and Grapefruit Juice
Grapefruit may affect how imatinib is processed in the body. Ask your treating specialist whether you should avoid it during treatment.
7. Other Cancer Medicines
Some cancer treatments may interact with imatinib or increase the chance of unwanted effects. Combined treatment should be reviewed by the treating specialist.
Important Reminder
Do not start, stop, or change any medicine without professional guidance. Keep an updated list of medicines and supplements and share it during medical appointments.
| Manufacturer | : | Sun Pharmaceutical Industries Ltd |
| Equivalent Brand | : | Gleevec |
| Generic Search | : | Imatinib mesylate |
Latest Products
